- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Equine Pharmaceuticals and Supplements market will register a 4.7% CAGR in terms of revenue, the global market size will reach $ 1314.6 million by 2025, from $ 1095.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Equine Pharmaceuticals and Supplements business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Pharmaceuticals and Supplements market by type, application, key manufacturers and key regions and countries.
This study considers the Equine Pharmaceuticals and Supplements value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Pharmaceuticals
Supplements
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Thoroughbred Horse
Other Types of Horses
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Boehringer Ingelheim
Kyoritsu Seiyaku
Merck Animal Health
Bayer Animal Health
Elanco Animal Health
Zoetis
Virbac
Dechra Veterinary Products
Norbrook Equine
CEVA
Vetoquinol
Ouro Fino Saude
Audevard
Protexin Healthcare
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Equine Pharmaceuticals and Supplements consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Equine Pharmaceuticals and Supplements market by identifying its various subsegments.
Focuses on the key global Equine Pharmaceuticals and Supplements manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Equine Pharmaceuticals and Supplements with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Equine Pharmaceuticals and Supplements submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Consumption 2015-2025
2.1.2 Equine Pharmaceuticals and Supplements Consumption CAGR by Region
2.2 Equine Pharmaceuticals and Supplements Segment by Type
2.2.1 Pharmaceuticals
2.2.2 Supplements
2.3 Equine Pharmaceuticals and Supplements Consumption by Type
2.3.1 Global Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
2.3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2015-2020)
2.3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Type (2015-2020)
2.4 Equine Pharmaceuticals and Supplements Segment by Application
2.4.1 Thoroughbred Horse
2.4.2 Other Types of Horses
2.5 Equine Pharmaceuticals and Supplements Consumption by Application
2.5.1 Global Equine Pharmaceuticals and Supplements Consumption Market Share by Type (2015-2020)
2.5.2 Global Equine Pharmaceuticals and Supplements Value and Market Share by Type (2015-2020)
2.5.3 Global Equine Pharmaceuticals and Supplements Sale Price by Type (2015-2020)
3 Global Equine Pharmaceuticals and Supplements by Company
3.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Company
3.1.1 Global Equine Pharmaceuticals and Supplements Sales by Company (2018-2020)
3.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Company (2018-2020)
3.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company
3.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Company (2018-2020)
3.2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Company (2018-2020)
3.3 Global Equine Pharmaceuticals and Supplements Sale Price by Company
3.4 Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Equine Pharmaceuticals and Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Equine Pharmaceuticals and Supplements by Regions
4.1 Equine Pharmaceuticals and Supplements by Regions
4.2 Americas Equine Pharmaceuticals and Supplements Consumption Growth
4.3 APAC Equine Pharmaceuticals and Supplements Consumption Growth
4.4 Europe Equine Pharmaceuticals and Supplements Consumption Growth
4.5 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption Growth
5 Americas
5.1 Americas Equine Pharmaceuticals and Supplements Consumption by Countries
5.1.1 Americas Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020)
5.1.2 Americas Equine Pharmaceuticals and Supplements Value by Countries (2015-2020)
5.2 Americas Equine Pharmaceuticals and Supplements Consumption by Type
5.3 Americas Equine Pharmaceuticals and Supplements Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Equine Pharmaceuticals and Supplements Consumption by Regions
6.1.1 APAC Equine Pharmaceuticals and Supplements Consumption by Regions (2015-2020)
6.1.2 APAC Equine Pharmaceuticals and Supplements Value by Regions (2015-2020)
6.2 APAC Equine Pharmaceuticals and Supplements Consumption by Type
6.3 APAC Equine Pharmaceuticals and Supplements Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Equine Pharmaceuticals and Supplements by Countries
7.1.1 Europe Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020)
7.1.2 Europe Equine Pharmaceuticals and Supplements Value by Countries (2015-2020)
7.2 Europe Equine Pharmaceuticals and Supplements Consumption by Type
7.3 Europe Equine Pharmaceuticals and Supplements Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Equine Pharmaceuticals and Supplements by Countries
8.1.1 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Equine Pharmaceuticals and Supplements Value by Countries (2015-2020)
8.2 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Type
8.3 Middle East & Africa Equine Pharmaceuticals and Supplements Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Equine Pharmaceuticals and Supplements Distributors
10.3 Equine Pharmaceuticals and Supplements Customer
11 Global Equine Pharmaceuticals and Supplements Market Forecast
11.1 Global Equine Pharmaceuticals and Supplements Consumption Forecast (2021-2025)
11.2 Global Equine Pharmaceuticals and Supplements Forecast by Regions
11.2.1 Global Equine Pharmaceuticals and Supplements Forecast by Regions (2021-2025)
11.2.2 Global Equine Pharmaceuticals and Supplements Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Equine Pharmaceuticals and Supplements Forecast by Type
11.8 Global Equine Pharmaceuticals and Supplements Forecast by Application
12 Key Players Analysis
12.1 Boehringer Ingelheim
12.1.1 Company Information
12.1.2 Equine Pharmaceuticals and Supplements Product Offered
12.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Boehringer Ingelheim Latest Developments
12.2 Kyoritsu Seiyaku
12.2.1 Company Information
12.2.2 Equine Pharmaceuticals and Supplements Product Offered
12.2.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Kyoritsu Seiyaku Latest Developments
12.3 Merck Animal Health
12.3.1 Company Information
12.3.2 Equine Pharmaceuticals and Supplements Product Offered
12.3.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Merck Animal Health Latest Developments
12.4 Bayer Animal Health
12.4.1 Company Information
12.4.2 Equine Pharmaceuticals and Supplements Product Offered
12.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Bayer Animal Health Latest Developments
12.5 Elanco Animal Health
12.5.1 Company Information
12.5.2 Equine Pharmaceuticals and Supplements Product Offered
12.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Elanco Animal Health Latest Developments
12.6 Zoetis
12.6.1 Company Information
12.6.2 Equine Pharmaceuticals and Supplements Product Offered
12.6.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Zoetis Latest Developments
12.7 Virbac
12.7.1 Company Information
12.7.2 Equine Pharmaceuticals and Supplements Product Offered
12.7.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Virbac Latest Developments
12.8 Dechra Veterinary Products
12.8.1 Company Information
12.8.2 Equine Pharmaceuticals and Supplements Product Offered
12.8.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Dechra Veterinary Products Latest Developments
12.9 Norbrook Equine
12.9.1 Company Information
12.9.2 Equine Pharmaceuticals and Supplements Product Offered
12.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Norbrook Equine Latest Developments
12.10 CEVA
12.10.1 Company Information
12.10.2 Equine Pharmaceuticals and Supplements Product Offered
12.10.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 CEVA Latest Developments
12.11 Vetoquinol
12.11.1 Company Information
12.11.2 Equine Pharmaceuticals and Supplements Product Offered
12.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Vetoquinol Latest Developments
12.12 Ouro Fino Saude
12.12.1 Company Information
12.12.2 Equine Pharmaceuticals and Supplements Product Offered
12.12.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Ouro Fino Saude Latest Developments
12.13 Audevard
12.13.1 Company Information
12.13.2 Equine Pharmaceuticals and Supplements Product Offered
12.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Audevard Latest Developments
12.14 Protexin Healthcare
12.14.1 Company Information
12.14.2 Equine Pharmaceuticals and Supplements Product Offered
12.14.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Protexin Healthcare Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Equine Pharmaceuticals and Supplements Consumption CAGR by Region 2015-2025 ($ Millions)
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
